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The Arclight is a cheap, solar powered ophthalmoscope and otoscope developed for users in low and middle income 
countries inspired by a BMJ Christmas article from 2000'. 
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“Wow, it really works!”—rural health worker, Malawi, 2016 
“Less is more”—Peter Behrens, Architect, 1868-1940 
Around 285 million people in the world are estimated to be visually impaired,1 and 360 million 
hearing impaired,2 with the majority of cases considered preventable or treatable if diagnosed 
promptly. Ophthalmoscopes and otoscopes are typically designed for wealthy countries and are 
complex, heavy, and expensive; their basic designs have remained relatively unchanged for over 100 
years.3 Very few practitioners in low and middle income countries have these essential tools. If they 
do, they are typically hand-me-downs that don’t work because they need parts that are hard to find or 
expensive, such as bulbs and batteries.4 The vast majority of cases of vision and hearing impairment 
are however found in these countries with least access to diagnostic tools. The Lancet Commission 
has recommended greater focus on frugal technologies designed for the needs of low and middle 
income countries.4 
Frugal inspiration from The BMJ at Christmas 
In 2000 the Christmas issue of The BMJ contained an article describing a cheap, homemade 
ophthalmoscope.5 This inspired the Arclight; a prototype pocket sized (110 mm  26 mm  9 mm, 
weight 18 g) ophthalmoscope, otoscope, and loupe powered by a slim rechargeable lithium battery 
that is charged by an integrated solar panel and illuminated by a patented LED light source (figs 1 
and 2).  
Fig 1 How Arclight works 
Fig 2 A pocket sized ophthalmoscope, otoscope, and loupe 
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The Fred Hollows Foundation offered seed development funding to develop the prototype into a 
device ready for market. The simplified design has considerably lower production costs, and the 
Arclight is now available to low income users through the standard list of the International Agency 
for Prevention of Blindness at a fraction of the cost of traditional devices.7 Several thousand devices 
have been distributed to countries around the world, including Malawi, Ethiopia, Kenya, Tanzania, 
Rwanda, Ghana, Fiji, Indonesia, and the Solomon Islands, enabling healthcare workers to perform 
comprehensive eye and ear examinations for the first time. 
Changing care 
The Arclight is tailored to the conditions and needs of low resource settings8 so that it can be 
used to identify the most common causes of vision and hearing loss. Although it is still in the early 
stages of evaluation, preliminary studies from Scotland, Malawi, and Tanzania indicate that the 
device is more effective than traditional tools for teaching ophthalmoscopy9 10 and is just as accurate 
for screening for signs of diabetic retinopathy and glaucoma.8 11. Studies for other conditions 
requiring a “red reflex” examination, such as congenital cataract and retinoblastoma, which if 
diagnosed late can lead to poor visual outcomes and even death, are currently under way. 
Consequently Sense International is usingthe Arclight in a large screening programme of infants 
aged 0-3 years in Kenya and Uganda.12 The loupe of the device is being used by the Fred Hollows 
Foundation in Ethiopia to screen for trachoma for the prevention of blindness that is estimated to 
affect over three million people worldwide.13 14 The otoscope has also been used in Malawi to 
identify and treat middle ear disease and cerumen impaction as part of a hearing impairment 
prevention programme.15  
Feedback from formal training with users in Malawi identified several barriers to care, including 
the need for access to relevant training material and local referral guidelines.[8] The next iteration of 
the Arclight contains a memory chip loaded with a multimedia training program accessible through a 
smartphone app.[19] The Arclight can also acquire digital images for remote interpretation and for 
training purposes by clipping to a mobile phone camera (fig 3).  
Fig 3 Device can be attached to a mobile phone 
The development of this device has created a piece of disruptive technology that has the potential 
to transform care in low and middle income countries. It all started with a paper in the millennial 
Christmas issue of The BMJ. So please keep reading the festive issue of the journal; you never know 
what ideas might light up. 
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conference in Hyderabad in 2012. AB is seconded to the University of St Andrews from NHS Fife. 
The University owns a social enterprise subsidiary company, for which AB acts as an unpaid adviser, 
which sells the Arclight to users in the UK with all profits being used to fund distribution and 
education exercises of the device in low income countries via the Global Health Implementation 
team at the University of St Andrews. 
In memory of Sandy Holt-Wilson. 
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